Merck Sharp & Dohme, s.r.o. (MSD Slovensko) is the Slovak subsidiary of Merck & Co., Inc., Rahway, NJ, USA, operating as a wholesale distributor and marketing organization for innovative human pharmaceuticals and vaccines. The company's business segments include the registration, promotion and distribution of prescription medicines and vaccines across therapeutic areas such as oncology, vaccines and infectious diseases, cardiometabolic diseases, immunology and hospital acute care, as well as coordination of pharmacovigilance and medical information services. As a wholesale entity it supplies its portfolio to wholesalers, hospitals, clinics and pharmacies throughout Slovakia, supported by a head office in Bratislava and a field force serving healthcare professionals nationwide. Through integration into MSD's regional and global network, the Slovak subsidiary also participates in clinical research activities and international medical and market access projects. MSD operates in Slovakia exclusively under the MSD / Merck Sharp & Dohme corporate brand, which represents its key intangible asset alongside its portfolio of innovative patented medicines and vaccines, established relationships with healthcare providers and payers, and robust compliance and quality systems. Strategically, Merck Sharp & Dohme, s.r.o. positions itself as a leading research based biopharmaceutical company in the Slovak market, focusing on bringing new therapies and vaccines to patients, supporting evidence based medicine and preventive care, cooperating with healthcare authorities on access and reimbursement solutions, and upholding high ethical and transparency standards in all interactions with the healthcare system.
Headquarters
Einsteinova, 19
Bratislava; Bratislavsky;
Postal Code: 85101
Contact Details: Purchase the Merck Sharp & Dohme, S.R.O. report to view the information.
Website: https://www.msd.sk
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service